From the Editor-in-Chief
Can cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
Your Tax Dollars at Work | Treatment Before Surgery | Opportunities for Prevention | Tinkering With T Cells | Palliative Care Can Help a Wide Range of Patients | Improving Patient Care Worldwide
Learn what questions to ask before participating in a study.
by Hester Hill Schnipper
Caregiving With Confidence
Shifting some responsibilities may empower your loved one and strengthen your relationship.
by Aimee Swartz
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
Advocacy In Action
Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
Vitamin D Doubts | A Virtuous Cycle
During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
Learn how to help a depressed parent with cancer.
Cancer survivor creates scholarship fund for young adult cancer survivors.
by Lindsey Konkel
Wanda Huskins, Renee Soriano, Holly Hamer.
Clinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR